Superficial bladder cancer: part 2. Management.
- 1 April 2007
- journal article
- review article
- Published by Taylor & Francis Ltd in Expert Review of Anticancer Therapy
- Vol. 7 (4), 567-581
- https://doi.org/10.1586/14737140.7.4.567
Abstract
In the second section of a two-part article, the recent literature is reviewed and the management of nonmuscle-invasive transitional cell carcinoma of the bladder is discussed. Particular attention is given to the indications and timing of intravesical chemotherapy and immunotherapy and the differences in efficacy and side-effect profiles of the available agents. The indications and role of second-look transurethral resection are reviewed. Additionally, the role of bacillus Calmette-Guerin in the management of this disease in terms of definitive treatment and maintenance therapy is discussed. We also offer a review of the literature regarding therapies for bacillus Calmette-Guerin-refractory nonmuscle-invasive transitional cell carcinoma of the bladder and their current place in practice.Keywords
This publication has 100 references indexed in Scilit:
- Intravesical bacillus Calmette‐Guèrin therapy: experience with a reduced dwell‐time in patients with pronounced side‐effectsBJU International, 2005
- UPDATE ON CHEMOTHERAPY FOR ADVANCED BLADDER CANCERJournal of Urology, 2005
- A Second-Look TUR in T1 Transitional Cell Carcinoma: Why?European Urology, 2004
- Second Transurethral Resection of Superficial Transitional Cell Carcinoma of the Bladder: A Must Even for Experienced UrologistsUrologia Internationalis, 2004
- Perioperative Single Dose Instillation of Epirubicin or Interferon-α After Transurethral Resection for The Prophylaxis of Primary Superficial Bladder Cancer Recurrence: A Prospective Randomized Multicenter Study—Finnbladder III Long-Term ResultsJournal of Urology, 2002
- Laser Treatment for Invasive and Noninvasive Carcinoma of the BladderJournal of Endourology, 2001
- THE CURRENT STATUS OF BLADDER PRESERVATION IN THE TREATMENT OF MUSCLE INVASIVE BLADDER CANCERJournal of Urology, 2000
- EFFICACY AND SAFETY OF VALRUBICIN FOR THE TREATMENT OF BACILLUS CALMETTE-GUERIN REFRACTORY CARCINOMA IN SITU OF THE BLADDERJournal of Urology, 2000
- Original Articles: Bladder Cancer: Intravesical Adjuvant Chemotherapy for Superficial Transitional Cell Bladder Carcinoma: Results of 2 European Organization for Research and Treatment of Cancer Randomized Trials With Mitomycin C and Doxorubicin Comparing Early Versus Delayed Instillations and Short-Term Versus Long-Term TreatmentJournal of Urology, 1995
- Diagnosis and management of superficial bladder cancerSeminars in Surgical Oncology, 1989